The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL
体能和剂量强度对慢性淋巴细胞白血病患者接受维奈托克-奥妥珠单抗治疗的临床疗效的影响
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2025028899
Al-Sawaf, Othman; Fürstenau, Moritz; Giza, Adam; Robrecht, Sandra; von Tresckow, Julia; Fink, Anna-Maria; Simon, Florian; Tausch, Eugen; Schneider, Christof; Sivcheva, Liliya; Schwarer, Anthony; Loscertales, Javier; Weinkove, Robert; Strumberg, Dirk; Kilfoyle, Allanah; Juliusson, Gunnar; da Cunha-Bang, Caspar; Illmer, Thomas; Gregor, Michael; Thornton, Patrick; Janssens, Ann; Tadmor, Tamar; Lindström, Vesa; Staber, Philipp; Levin, Mark-David; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Ritgen, Matthias; Stilgenbauer, Stephan; Kater, Arnon P; Niemann, Carsten; Fischer, Kirsten; Eichhorst, Barbara; Hallek, Michael